Sanjay A Desai

USPTO Granted Patents = 10 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 20(Granted Patents)

Location History:

Golden, CO (US) (2018)
Potomac, MD (US) (2013 - 2024)

Company Filing History:

10 out of 3,540

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

1 out of 183

Trustees of the Colorado School of Mines

patents

1 out of 1,942

University System of Maryland

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12059418 - Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria (2024-08-13),

2. 10881669 - Inhibitors of the plasmodial surface anion channel as antimalarials (2021-01-05),

3. 10869865 - Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria (2020-12-22),

4. 10265313 - Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria (2019-04-23),

5. 9974796 - Inhibitors of the plasmodial surface anion channel as antimalarials (2018-05-22),

6. 9885644 - Dynamic viscoelasticity as a rapid single-cell biomarker (2018-02-06),

7. 9808458 - Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria (2017-11-07),

8. 9394316 - Inhibitors of the plasmodial surface anion channel as antimalarials (2016-07-19),

9. 9320786 - Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria (2016-04-26),

10. 8618090 - Inhibitors of the plasmodial surface anion channel as antimalarials (2013-12-31),

Title: Sanjay A Desai: Innovator in Malaria Treatment

Introduction

Sanjay A Desai is a prominent inventor based in Potomac, MD (US), known for his significant contributions to the field of malaria treatment. With a total of 10 patents, his work focuses on innovative methods to combat this life-threatening disease.

Latest Patents

Among his latest patents, Desai has developed methods for treating or preventing malaria through the use of plasmodial surface anion channel inhibitors. One notable invention provides pharmaceutical compositions that include a compound represented by a specific formula, aimed at inhibiting the plasmodial surface anion channel in animals, including humans. This invention not only outlines the methods of treatment but also includes clag3 amino acid sequences, related nucleic acids, vectors, host cells, and antibodies.

Another significant patent involves the use of inhibitors of the plasmodial surface anion channel as antimalarials. This patent discloses various inhibitors and their application in treating or preventing malaria in humans, emphasizing the importance of effective compounds in the fight against this disease.

Career Highlights

Sanjay A Desai has had a distinguished career, working with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute significantly to public health and medical research.

Collaborations

Throughout his career, Desai has collaborated with notable colleagues, including Ajay D Pillai, enhancing the impact of his research and innovations in the field of malaria treatment.

Conclusion

Sanjay A Desai's innovative work in developing treatments for malaria showcases his dedication to improving global health. His patents reflect a commitment to finding effective solutions to combat this serious disease.

This text is generated by artificial intelligence and may not be accurate.